LakeShore Biopharma Co., Ltd (LSB)
NASDAQ: LSB · Real-Time Price · USD
2.940
+0.140 (5.00%)
Dec 2, 2024, 4:00 PM EST - Market closed

LakeShore Biopharma Revenue

In the fiscal year ending March 31, 2024, LakeShore Biopharma had annual revenue of 573.42M CNY, down -16.56%. LakeShore Biopharma had revenue of 135.35M in the quarter ending March 31, 2024, with 27.67% growth.

Revenue (ttm)
573.42M CNY
Revenue Growth
-16.56%
P/S Ratio
0.40
Revenue / Employee
756,488 CNY
Employees
758
Market Cap
56.10M undefined

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024573.42M-113.78M-16.56%
Mar 31, 2023687.20M184.25M36.63%
Mar 31, 2022502.95M245.93M95.69%
Mar 31, 2021257.02M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.